Literature DB >> 22031698

Resistance of Akt kinases to dephosphorylation through ATP-dependent conformational plasticity.

Tung O Chan1, Jin Zhang, Ulrich Rodeck, John M Pascal, Roger S Armen, Maureen Spring, Calin D Dumitru, Valerie Myers, Xue Li, Joseph Y Cheung, Arthur M Feldman.   

Abstract

Phosphorylation of a threonine residue (T308 in Akt1) in the activation loop of Akt kinases is a prerequisite for deregulated Akt activity frequently observed in neoplasia. Akt phosphorylation in vivo is balanced by the opposite activities of kinases and phosphatases. Here we describe that targeting Akt kinase to the cell membrane markedly reduced sensitivity of phosphorylated Akt to dephosphorylation by protein phosphatase 2A. This effect was amplified by occupancy of the ATP binding pocket by either ATP or ATP-competitive inhibitors. Mutational analysis revealed that R273 in Akt1 and the corresponding R274 in Akt2 are essential for shielding T308 in the activation loop against dephosphorylation. Thus, occupancy of the nucleotide binding pocket of Akt kinases enables intramolecular interactions that restrict phosphatase access and sustain Akt phosphorylation. This mechanism provides an explanation for the "paradoxical" Akt hyperphosphorylation induced by ATP-competitive inhibitor, A-443654. The lack of phosphatase resistance further contributes insight into the mechanism by which the human Akt2 R274H missense mutation may cause autosomal-dominant diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22031698      PMCID: PMC3219155          DOI: 10.1073/pnas.1109879108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

Review 1.  The conformational plasticity of protein kinases.

Authors:  Morgan Huse; John Kuriyan
Journal:  Cell       Date:  2002-05-03       Impact factor: 41.582

2.  Protein phosphatase 2A is the main phosphatase involved in the regulation of protein kinase B in rat adipocytes.

Authors:  Svante Resjö; Olga Göransson; Linda Härndahl; Stanislaw Zolnierowicz; Vincent Manganiello; Eva Degerman
Journal:  Cell Signal       Date:  2002-03       Impact factor: 4.315

3.  Briefly bound to activate: transient binding of a second catalytic magnesium activates the structure and dynamics of CDK2 kinase for catalysis.

Authors:  Zhao Qin Bao; Douglas M Jacobsen; Matthew A Young
Journal:  Structure       Date:  2011-05-11       Impact factor: 5.006

Review 4.  AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation.

Authors:  T O Chan; S E Rittenhouse; P N Tsichlis
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

5.  Dephosphorylation of PKCdelta by protein phosphatase 2Ac and its inhibition by nucleotides.

Authors:  Jyoti Srivastava; Jozef Goris; Stephen M Dilworth; Peter J Parker
Journal:  FEBS Lett       Date:  2002-04-10       Impact factor: 4.124

Review 6.  Protein kinase B (PKB/Akt), a key mediator of the PI3K signaling pathway.

Authors:  Elisabeth Fayard; Gongda Xue; Arnaud Parcellier; Lana Bozulic; Brian A Hemmings
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

7.  Interference with PDK1-Akt survival signaling pathway by UCN-01 (7-hydroxystaurosporine).

Authors:  Saori Sato; Naoya Fujita; Takashi Tsuruo
Journal:  Oncogene       Date:  2002-03-07       Impact factor: 9.867

8.  A transition path ensemble study reveals a linchpin role for Mg(2+) during rate-limiting ADP release from protein kinase A.

Authors:  Ilja V Khavrutskii; Barry Grant; Susan S Taylor; J Andrew McCammon
Journal:  Biochemistry       Date:  2009-12-08       Impact factor: 3.162

9.  Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibition.

Authors:  Wen-I Wu; Walter C Voegtli; Hillary L Sturgis; Faith P Dizon; Guy P A Vigers; Barbara J Brandhuber
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

10.  Inhibitor hijacking of Akt activation.

Authors:  Tatsuya Okuzumi; Dorothea Fiedler; Chao Zhang; Daniel C Gray; Brian Aizenstein; Randy Hoffman; Kevan M Shokat
Journal:  Nat Chem Biol       Date:  2009-05-24       Impact factor: 15.040

View more
  42 in total

1.  Ligand binding to the AMP-activated protein kinase active site mediates protection of the activation loop from dephosphorylation.

Authors:  Dakshayini G Chandrashekarappa; Rhonda R McCartney; Martin C Schmidt
Journal:  J Biol Chem       Date:  2012-11-26       Impact factor: 5.157

2.  A truncated fragment of Src protein kinase generated by calpain-mediated cleavage is a mediator of neuronal death in excitotoxicity.

Authors:  M Iqbal Hossain; Carli L Roulston; M Aizuddin Kamaruddin; Percy W Y Chu; Dominic C H Ng; Gregory J Dusting; Jeffrey D Bjorge; Nicholas A Williamson; Donald J Fujita; Steve N Cheung; Tung O Chan; Andrew F Hill; Heung-Chin Cheng
Journal:  J Biol Chem       Date:  2013-02-11       Impact factor: 5.157

Review 3.  Autoregulation of kinase dephosphorylation by ATP binding in AGC protein kinases.

Authors:  Tung O Chan; John M Pascal; Roger S Armen; Ulrich Rodeck
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

4.  A tripartite cooperative mechanism confers resistance of the protein kinase A catalytic subunit to dephosphorylation.

Authors:  Tung O Chan; Roger S Armen; Santosh Yadav; Sushrut Shah; Jin Zhang; Brian C Tiegs; Nikhil Keny; Brian Blumhof; Deepak A Deshpande; Ulrich Rodeck; Raymond B Penn
Journal:  J Biol Chem       Date:  2020-01-21       Impact factor: 5.157

5.  Candidate tumor suppressor and pVHL partner Jade-1 binds and inhibits AKT in renal cell carcinoma.

Authors:  Liling Zeng; Ming Bai; Amit K Mittal; Wassim El-Jouni; Jing Zhou; David M Cohen; Mina I Zhou; Herbert T Cohen
Journal:  Cancer Res       Date:  2013-07-01       Impact factor: 12.701

6.  Protein kinase d inhibitors uncouple phosphorylation from activity by promoting agonist-dependent activation loop phosphorylation.

Authors:  Maya T Kunkel; Alexandra C Newton
Journal:  Chem Biol       Date:  2014-12-31

7.  Intracellular distribution of differentially phosphorylated dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A).

Authors:  Wojciech Kaczmarski; Madhabi Barua; Bozena Mazur-Kolecka; Janusz Frackowiak; Wieslaw Dowjat; Pankaj Mehta; David Bolton; Yu-Wen Hwang; Ausma Rabe; Giorgio Albertini; Jerzy Wegiel
Journal:  J Neurosci Res       Date:  2013-11-22       Impact factor: 4.164

8.  The Mechanism of ATP-Dependent Allosteric Protection of Akt Kinase Phosphorylation.

Authors:  Shaoyong Lu; Rong Deng; Haiming Jiang; Huili Song; Shuai Li; Qiancheng Shen; Wenkang Huang; Ruth Nussinov; Jianxiu Yu; Jian Zhang
Journal:  Structure       Date:  2015-08-06       Impact factor: 5.006

Review 9.  Targeting the PI3K/Akt/mTOR pathway for breast cancer therapy.

Authors:  Justin Cidado; Ben Ho Park
Journal:  J Mammary Gland Biol Neoplasia       Date:  2012-08-04       Impact factor: 2.673

Review 10.  Protein kinase C pharmacology: refining the toolbox.

Authors:  Alyssa X Wu-Zhang; Alexandra C Newton
Journal:  Biochem J       Date:  2013-06-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.